PIB Bulletin Update on COVID-19

0
38
PIB’S BULLETIN ON COVID-19
PIB’S BULLETIN ON COVID-19

PIB News Update:

  • Government monitoring supply of each COVID-19 Essential Drug
  • Daily Recoveries Outnumber Daily New Cases for the 6th Consecutive Day
  • Government of India provides advance information on Vaccine Doses Supply availability till 15th June 2021 to States and UTs

#Unite2FightCorona

#IndiaFightsCorona

PRESS INFORMATION BUREAU

MINISTRY OF INFORMATION AND BROADCASTING

GOVERNMENT OF INDIA

Daily Recoveries Outnumber Daily New Cases for the 6th Consecutive Day

  • Less than 3 Lakh daily New Cases for three successive days
  • Highest ever 20 Lakh Tests Conducted in the last 24 hours which is a global record
  • Daily Positivity Rate Declines to 13.31%
  • More than 64 lakh beneficiaries of age group 18-44 Vaccinated, so far

For Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1719843

Government of India provides advance information on Vaccine Doses Supply availability till 15th June 2021 to States and UTs

States advised to prepare a district-wise, COVID Vaccination Centre (CVC) wise plan for administration of COVID vaccines in advance and publicise it.
CVCs to publish calendars on CoWIN in advance to prevent overcrowding at Vaccination Centres

For Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1719837

New AIIMS started under Pradhan Mantri Swasthya Suraksha Yojana are providing advanced COVID Care in States

Pradhan Mantri Swasthya Suraksha Yojana (PMSSY), a Central Sector Scheme, was announced in August 2003 to address imbalances in availability of tertiary care hospitals and improve medical education in the country.

For Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1719809

Government monitoring supply of each COVID-19 Essential Drug

Minister of State Shri Mansukh Mandaviya today assured that the Government is monitoring supply of each COVID-19 Essential Drug. All drugs used in the management of COVID-19 are now available in India by ramping up production and increasing the imports. The availability of these drugs is being monitored by implementing three-pronged strategy of Supply Chain Management, Demand Side Management and Affordability.

For Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1719867

PIB FACT CHCEK